Standard AOD-9604 Dosing Protocol Subcutaneous Injection Dosing: Beginner: 250 mcg per dose, once daily Intermediate: 300-400 mcg per dose, once daily or divided into two doses Advanced: 500 mcg per dose, once daily or 250 mcg twice daily Oral Administration Dosing (if using oral formulation): Standard: 1-2 mg per dose, once daily on empty stomach Higher protocols: Up to 5-10 mg daily, as studied in clinical trials Frequency: Once daily (morning preferred) or twice daily (morning and early afternoon) Timing: Best administered on an empty stomach, typically upon waking or before exercise Cycle Length: 12-16 weeks for initial assessment, with potential for longer protocols based on response Off Cycle: 4-8 weeks between cycles, though not strictly required based on current research Note: Start at the lower end of the dosing range to assess individual tolerance
Once reconstituted with bacteriostatic water, the solution requires refrigeration at 2 to 8 degrees Celsius and should be used within 30 days
10.1016/j.neuroscience.2012.09.025 [DOI] [PubMed] [Google Scholar] Weston, C
It is hoped that the central role of the intestinal epithelium in this regulation will become more evident
Here are some of the most interesting studies regarding the GH-boosting potential of each peptide: CJC-1295 has been administered to healthy young and middle-aged study volunteers as a single dose, ranging between 30mcg/kg and 250mcg/kg of body weight
